Award-Winning Bioinformatics: Why Dotmatics Was Recognised in 2022
Dotmatics was recognized as the 2022 Bioinformatics Solution of the Year in the second annual BioTech Breakthrough Awards, which evaluated over 1,350 global nominations based on innovation, performance, usability, functionality, value, and impact, highlighting Dotmatics' integrated R&D platform that addresses complex scientific data challenges in biotechnology and life sciences.
Recognized in Second Annual Biotech Breakthrough Awards
The annual BioTech Breakthrough Awards program aims to conduct the industry’s most comprehensive analysis and evaluation of the top technology companies, solutions, and products in the life sciences and biotechnology industry. The 2022 program attracted more than 1,350 nominations from countries around the world.
Steve Tharp, SVP Customer Ops at Dotmatics, stated: “The spirit of the BioTech Breakthrough Awards is to highlight the truly breakthrough products, solutions, and companies within the crowded biotechnology and life sciences markets. This is an important win for the Dotmatics team because the Awards have earned a reputation for fairness and credibility, and previous winners demonstrate the caliber of companies involved. Dotmatics is honored to be the Bioinformatics Solution of the Year.”
The winning BioTech Breakthrough selections showcase technologies and companies that push ingenuity and exemplify the best in biotechnology solutions globally. Each was judged on the following criteria:
- Innovation
- Performance
- Ease-of-Use and Manageability
- Functionality
- Value
- Impact
Bryan Vaughn, Managing Director of BioTech Breakthrough Awards, commented: “Advances in biological sciences, combined with accelerating development of computing, data processing, and AI are fueling a new wave of innovation in the healthcare sector. These advances are providing new understanding, new materials, new tools, as well as lower costs. It’s an exciting time in the industry and we are thrilled to highlight the ‘breakthrough’ biotechnology solutions, services, and companies around the world for our 2022 program. We extend our sincerest congratulations to our 2022 BioTech Breakthrough Award winners.”
The Dotmatics team is developing an integrated R&D platform with the depth, breadth, and connectivity to the best scientific applications to help solve the complex data challenges scientists face in lab environments. More than 2 million scientists and 10,000 customers trust Dotmatics to help them create a healthier, cleaner, safer world. The global team of more than 800 people is dedicated to supporting customers in over 180 countries.
Related
Dotmatics Set to Transform the Future of Scientific Software and Data Management
Dotmatics, formed from the merger of Insightful Science and Dotmatics, is launching a powerful integrated enterprise R&D platform combining its scientific software with popular applications like SnapGene, Geneious, and GraphPad Prism to address complex data challenges and accelerate scientific research and collaboration for over two million scientists and 10,000 customers worldwide.
Joining Forces with Insightful Science
Dotmatics and Insightful Science have merged to form the world’s largest cloud-based scientific research R&D platform, combining their software solutions to accelerate innovation, enhance data-driven research workflows, and drive the digital transformation of scientific labs into the Lab of the Future.
Winner of 2022 Healthcare & Pharmaceutical Awards
Dotmatics was named “Best Scientific R&D Software Developer & Cloud Vendor” at the 2022 Global Health & Pharma’s Healthcare & Pharmaceutical Awards for its integrated R&D platform that addresses scientific data challenges and supports over 2 million scientists worldwide in accelerating life-saving research amid the heightened demands highlighted by the COVID-19 pandemic.
Dotmatics introduces Luma Agent: the AI co-scientist built on structured scientific data
Dotmatics has launched Luma Agent, an AI co-scientist integrated into its Luma Scientific Intelligence Platform, which leverages structured, ontology-backed scientific data to autonomously plan, execute, and manage complex scientific workflows—including data analysis, reporting, and platform configuration—delivering fully traceable, verifiable, and reproducible results with human-approved actions to accelerate lab work from days to minutes while ensuring governance and accountability.
NBC News: How AI is Transforming Drug Discovery
In an NBC News segment, Alister Campbell, VP of Dotmatics, explains how the company leverages AI to analyze large datasets, predict effective drug compounds, and streamline fragmented data systems and manual workflows, thereby accelerating and improving the efficiency of drug discovery.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.